{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:34:45Z","timestamp":1791599685658,"version":"4.3.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00381-018-3833-7","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T15:29:49Z","timestamp":1527175789000},"page":"1311-1323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2194-7239","authenticated-orcid":false,"given":"Marcello","family":"Scala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Fiaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Capra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Garr\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ravegnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pavanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"issue":"1","key":"3833_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/jmedgenet-2013-101951","volume":"51","author":"B Adviento","year":"2014","unstructured":"Adviento B, Corbin IL, Widjaja F, Desachy G, Enrique N, Rosser T, Risi S, Marco EJ, Hendren RL, Bearden CE, Rauen KA, Weiss LA (2014) Autism traits in the RASopathies. J Med Genet 51(1):10\u201320. \n                    https:\/\/doi.org\/10.1136\/jmedgenet-2013-101951","journal-title":"J Med Genet"},{"issue":"5629","key":"3833_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.1082015","volume":"301","author":"A Alavi","year":"2003","unstructured":"Alavi A, Hood JD, Frausto R, Stupack DG, Cheresh DA (2003) Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301(5629):94\u201396","journal-title":"Science"},{"issue":"3","key":"3833_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ajmg.c.30138","volume":"145C","author":"JE Allanson","year":"2007","unstructured":"Allanson JE (2007) Noonan syndrome. Am J Med Genet C: Semin Med Genet 145C(3):274\u2013249. \n                    https:\/\/doi.org\/10.1002\/ajmg.c.30138","journal-title":"Am J Med Genet C: Semin Med Genet"},{"key":"3833_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.freeradbiomed.2016.06.002","volume":"97","author":"WK Bessler","year":"2016","unstructured":"Bessler WK, Hudson FZ, Zhang H, Harris V, Wang Y, Mund JA, Downing B, Ingram DA Jr, Case J, Fulton DJ, Stansfield BK (2016) Neurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humans. Free Radic Biol Med 97:212\u2013222. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.06.002","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"3833_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/hmg\/ddv635","volume":"25","author":"WK Bessler","year":"2016","unstructured":"Bessler WK, Kim G, Hudson FZ, Mund JA, Mali R, Menon K, Kapur R, Clapp DW, Ingram DA Jr, Stansfield BK (2016) Nf1+\/\u2212 monocytes\/macrophages induce neointima formation via CCR2 activation. Hum Mol Genet 25(6):1129\u20131139. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddv635","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3833_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/01.STR.26.1.131","volume":"26","author":"M Bitzer","year":"1995","unstructured":"Bitzer M, Topka H (1995) Progressive cerebral occlusive disease after radiation therapy. Stroke 26(1):131\u2013136","journal-title":"Stroke"},{"issue":"7","key":"3833_CR7","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/STROKEAHA.111.000307","volume":"44","author":"RS Bower","year":"2013","unstructured":"Bower RS, Mallory GW, Nwojo M, Kudva YC, Flemming KD, Meyer FB (2013) Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease. Stroke 44(7):1997\u20131999. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.111.000307","journal-title":"Stroke"},{"issue":"10","key":"3833_CR8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/jnnp.2007.136457","volume":"79","author":"AG Cairns","year":"2008","unstructured":"Cairns AG, North KN (2008) Cerebrovascular dysplasia in neurofibromatosis type 1. J Neurol Neurosurg Psychiatry 79(10):1165\u20131170. \n                    https:\/\/doi.org\/10.1136\/jnnp.2007.136457","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"3833_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3171\/2010.4.JNS091808","volume":"113","author":"L Calviere","year":"2010","unstructured":"Calviere L, Catalaa I, Marlats F, Viguier A, Bonneville F, Cognard C, Larrue V (2010) Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease. J Neurosurg 113(4):753\u2013759. \n                    https:\/\/doi.org\/10.3171\/2010.4.JNS091808","journal-title":"J Neurosurg"},{"issue":"1","key":"3833_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1227\/NEU.0b013e3181fc5ec2","volume":"68","author":"JR Dusick","year":"2011","unstructured":"Dusick JR, Gonzalez NR, Martin NA (2011) Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery 68(1):34\u201343; discussion 43. \n                    https:\/\/doi.org\/10.1227\/NEU.0b013e3181fc5ec2","journal-title":"Neurosurgery"},{"issue":"10","key":"3833_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/BF00300998","volume":"11","author":"M Ezura","year":"1995","unstructured":"Ezura M, Yoshimoto T, Fujiwara S, Takahashi A, Shirane R, Mizoi K (1995) Clinical and angiographic follow-up of childhood-onset moyamoya disease. Childs Nerv Syst 11(10):591\u2013594","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"3833_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ppedcard.2015.01.002","volume":"39","author":"BD Gelb","year":"2015","unstructured":"Gelb BD, Roberts AE, Tartaglia M (2015) Cardiomyopathies in Noonan syndrome and the other RASopathies. Prog Pediatr Cardiol 39(1):13\u201319. \n                    https:\/\/doi.org\/10.1016\/j.ppedcard.2015.01.002","journal-title":"Prog Pediatr Cardiol"},{"issue":"1","key":"3833_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0883073812441059","volume":"28","author":"PS Ghosh","year":"2013","unstructured":"Ghosh PS, Rothner AD, Emch TM, Friedman NR, Moodley M (2013) Cerebral vasculopathy in children with neurofibromatosis type 1. J Child Neurol 28(1):95\u2013101. \n                    https:\/\/doi.org\/10.1177\/0883073812441059","journal-title":"J Child Neurol"},{"issue":"5","key":"3833_CR14","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00701-014-2013-0","volume":"156","author":"K Hayashi","year":"2014","unstructured":"Hayashi K, Horie N, Izumo T, Nagata I (2014) Nationwide survey on quasi-moyamoya disease in Japan. Acta Neurochir 156(5):935\u2013940. \n                    https:\/\/doi.org\/10.1007\/s00701-014-2013-0","journal-title":"Acta Neurochir"},{"issue":"3","key":"3833_CR15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/pbc.25271","volume":"62","author":"N Hyakuna","year":"2015","unstructured":"Hyakuna N, Muramatsu H, Higa T, Chinen Y, Wang X, Kojima S (2015) Germline mutation of CBL is associated with moyamoya disease in a child with juvenile myelomonocytic leukemia and Noonan syndrome-like disorder. Pediatr Blood Cancer 62(3):542\u2013544. \n                    https:\/\/doi.org\/10.1002\/pbc.25271","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"3833_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","volume":"65","author":"SL Hyman","year":"2005","unstructured":"Hyman SL, Shores A, North KN (2005) The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 65(7):1037\u20131044. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000179303.72345.ce","journal-title":"Neurology"},{"issue":"5","key":"3833_CR17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.wneu.2015.01.016","volume":"83","author":"H Imai","year":"2015","unstructured":"Imai H, Miyawaki S, Ono H, Nakatomi H, Yoshimoto Y, Saito N (2015) The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults. World Neurosurg 83(5):691\u2013699. \n                    https:\/\/doi.org\/10.1016\/j.wneu.2015.01.016","journal-title":"World Neurosurg"},{"issue":"6","key":"3833_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1055\/s-2007-973508","volume":"30","author":"C Imaizumi","year":"1999","unstructured":"Imaizumi C, Imaizumi T, Osawa M, Fukuyama Y, Takeshita M (1999) Serial intelligence test scores in pediatric moyamoya disease. Neuropediatrics 30(6):294\u2013299. \n                    https:\/\/doi.org\/10.1055\/s-2007-973508","journal-title":"Neuropediatrics"},{"issue":"5","key":"3833_CR19","doi-asserted-by":"publisher","first-page":"e694","DOI":"10.1542\/peds.2005-0568","volume":"116","author":"A Jea","year":"2005","unstructured":"Jea A, Smith ER, Robertson R, Scott RM (2005) Moyamoya syndrome associated with down syndrome: outcome after surgical revascularization. Pediatrics 116(5):e694\u2013e701. \n                    https:\/\/doi.org\/10.1542\/peds.2005-0568","journal-title":"Pediatrics"},{"issue":"7","key":"3833_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/0961203307087375","volume":"17","author":"HC Jeong","year":"2008","unstructured":"Jeong HC, Kim YJ, Yoon W, Joo SP, Lee SS, Park YW (2008) Moyamoya syndrome associated with systemic lupus erythematosus. Lupus 17(7):679\u2013682. \n                    https:\/\/doi.org\/10.1177\/0961203307087375","journal-title":"Lupus"},{"key":"3833_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S (2011) A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56:34\u201340","journal-title":"J Hum Genet"},{"key":"3833_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2176\/nmc.17pt1.29","volume":"17","author":"J Karasawa","year":"1977","unstructured":"Karasawa J, Kikuchi H, Furuse S, Sakaki T, Yoshida Y (1977) A surgical treatment of \u201cmoyamoya\u201d disease, \u201cencephalo-myosynangiosis\u201d. Neurol Med Chir 17:29\u201337","journal-title":"Neurol Med Chir"},{"issue":"3","key":"3833_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3171\/jns.2000.93.3.0397","volume":"93","author":"S Kawaguchi","year":"2000","unstructured":"Kawaguchi S, Okuno S, Sakaki T (2000) Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 93(3):397\u2013401. \n                    https:\/\/doi.org\/10.3171\/jns.2000.93.3.0397","journal-title":"J Neurosurg"},{"issue":"2","key":"3833_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3171\/2014.1.JNS13946","volume":"121","author":"K Kazumata","year":"2014","unstructured":"Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, Kuroda S, Ishikawa T, Kamiyama H (2014) The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. J Neurosurg 121(2):432\u2013440","journal-title":"J Neurosurg"},{"issue":"1","key":"3833_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3171\/jns.1993.79.1.0032","volume":"79","author":"JR Kestle","year":"1993","unstructured":"Kestle JR, Hoffman HJ, Mock AR (1993) Moyamoya phenomenon after radiation for optic glioma. J Neurosurg 79(1):32\u201335. \n                    https:\/\/doi.org\/10.3171\/jns.1993.79.1.0032","journal-title":"J Neurosurg"},{"issue":"5","key":"3833_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3171\/2015.4.JNS142900","volume":"124","author":"EH Kim","year":"2016","unstructured":"Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, Goo HW, Ko TS, Yoo HW (2016) Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg 124(5):1221\u20131227. \n                    https:\/\/doi.org\/10.3171\/2015.4.JNS142900","journal-title":"J Neurosurg"},{"issue":"2","key":"3833_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000330541","volume":"47","author":"TG Kim","year":"2011","unstructured":"Kim TG, Kim DS, Chung SS, Choi JU (2011) Moyamoya syndrome after radiation therapy: case reports. Pediatr Neurosurg 47(2):138\u2013142. \n                    https:\/\/doi.org\/10.1159\/000330541","journal-title":"Pediatr Neurosurg"},{"issue":"4","key":"3833_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3171\/2012.12.PEDS12281","volume":"11","author":"M Koss","year":"2013","unstructured":"Koss M, Scott RM, Irons MB, Smith ER, Ullrich NJ (2013) Moyamoya syndrome associated with neurofibromatosis type 1: perioperative and long-term outcome after surgical revascularization. J Neurosurg Pediatr 11(4):417\u2013425. \n                    https:\/\/doi.org\/10.3171\/2012.12.PEDS12281","journal-title":"J Neurosurg Pediatr"},{"issue":"8","key":"3833_CR29","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/bjc.2015.75","volume":"112","author":"CP Kratz","year":"2015","unstructured":"Kratz CP, Franke L, Peters H, Kohlschmidt N, Kazmierczak B, Finckh U, Bier A, Eichhorn B, Blank C, Kraus C, Kohlhase J, Pauli S, Wildhardt G, Kutsche K, Auber B, Christmann A, Bachmann N, Mitter D, Cremer FW, Mayer K, Daumer-Haas C, Nevinny-Stickel-Hinzpeter C, Oeffner F, Schl\u00fcter G, Gencik M, \u00dcberlacker B, Lissewski C, Schanze I, Greene MH, Spix C, Zenker M (2015) Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes. Br J Cancer 112(8):1392\u20131397. \n                    https:\/\/doi.org\/10.1038\/bjc.2015.75","journal-title":"Br J Cancer"},{"issue":"2","key":"3833_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ajmg.c.30300","volume":"157C","author":"CP Kratz","year":"2011","unstructured":"Kratz CP, Rapisuwon S, Reed H, Hasle H, Rosenberg PS (2011) Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. Am J Med Genet C Semin Med Genet 157C(2):83\u201389. \n                    https:\/\/doi.org\/10.1002\/ajmg.c.30300","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"3","key":"3833_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2176\/nmc.ra.2014-0305","volume":"55","author":"S Kuroda","year":"2015","unstructured":"Kuroda S (2015) Asymptomatic moyamoya disease: literature review and ongoing AMORE study. Neurol Med Chir (Tokyo) 55(3):194\u2013198. \n                    https:\/\/doi.org\/10.2176\/nmc.ra.2014-0305","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"11","key":"3833_CR32","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda S, Houkin K (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7(11):1056\u20131066. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(08)70240-0","journal-title":"Lancet Neurol"},{"issue":"5","key":"3833_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00381-004-0924-4","volume":"20","author":"S Kuroda","year":"2004","unstructured":"Kuroda S, Houkin K, Ishikawa T, Nakayama N, Ikeda J, Ishii N, Kamiyama H, Iwasaki Y (2004) Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis. Childs Nerv Syst 20(5):302\u2013308","journal-title":"Childs Nerv Syst"},{"issue":"15","key":"3833_CR34","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/hmg\/ddn134","volume":"17","author":"EA Lasater","year":"2008","unstructured":"Lasater EA, Bessler WK, Mead LE, Horn WE, Clapp DW, Conway SJ, Ingram DA, Li F (2008) Nf1+\/\u2212 mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway. Hum Mol Genet 17(15):2336\u20132344. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddn134","journal-title":"Hum Mol Genet"},{"issue":"6","key":"3833_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3340\/jkns.2011.50.6.535","volume":"50","author":"HS Lee","year":"2011","unstructured":"Lee HS, Seol HJ, Kong DS, Shin HJ (2011) Moyamoya syndrome precipitated by cranial irradiation for craniopharyngioma in children. J Korean Neurosurg Soc 50(6):535\u2013537. \n                    https:\/\/doi.org\/10.3340\/jkns.2011.50.6.535","journal-title":"J Korean Neurosurg Soc"},{"issue":"11","key":"3833_CR36","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/hmg\/ddl114","volume":"15","author":"F Li","year":"2006","unstructured":"Li F, Munchhof AM, White HA, Mead LE, Krier TR, Fenoglio A, Chen S, Wu X, Cai S, Yang FC, Ingram DA (2006) Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells. Hum Mol Genet 15(11):1921\u20131930. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddl114","journal-title":"Hum Mol Genet"},{"issue":"6","key":"3833_CR37","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2011.10.FOCUS11228","volume":"31","author":"N Lin","year":"2011","unstructured":"Lin N, Baird L, Koss M, Kopecky KE, Gone E, Ullrich NJ, Scott RM, Smith ER (2011) Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression. Neurosurg Focus 31(6):E6. \n                    https:\/\/doi.org\/10.3171\/2011.10.FOCUS11228","journal-title":"Neurosurg Focus"},{"issue":"4","key":"3833_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0090-3019(81)80017-1","volume":"15","author":"Y Matsushima","year":"1981","unstructured":"Matsushima Y, Fukai N, Tanaka K, Tsuruoka S, Inaba Y, Aoyagi M, Ohno K (1981) A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol 15(4):313\u2013320","journal-title":"Surg Neurol"},{"key":"3833_CR39","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2147\/NDT.S75038","volume":"11","author":"CS Miguel","year":"2015","unstructured":"Miguel CS, Chaim-Avancini TM, Silva MA, Louz\u00e3 MR (2015) Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review. Neuropsychiatr Dis Treat 11:815\u2013821. \n                    https:\/\/doi.org\/10.2147\/NDT.S75038","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"24 Pt 2","key":"3833_CR40","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1212\/01.wnl.0000291012.49986.f9","volume":"70","author":"Y Mineharu","year":"2008","unstructured":"Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, Ikeda H, Houkin K, Takagi Y, Kikuta K, Nozaki K, Hashimoto N, Koizumi A (2008) Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70(24 Pt 2):2357\u20132363. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000291012.49986.f9.Epub2008May7","journal-title":"Neurology"},{"issue":"10","key":"3833_CR41","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1161\/STROKEAHA.113.002477","volume":"44","author":"S Miyawaki","year":"2013","unstructured":"Miyawaki S, Imai H, Shimizu M, Yagi S, Ono H, Mukasa A, Nakatomi H, Shimizu T, Saito N (2013) Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis\/occlusion. Stroke 44(10):2894\u20132897. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.113.002477.","journal-title":"Stroke"},{"issue":"6","key":"3833_CR42","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/0090-3019(95)00475-0","volume":"45","author":"K Mizoi","year":"1996","unstructured":"Mizoi K, Kayama T, Yoshimoto T, Nagamine Y (1996) Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients? Surg Neurol 45(6):541\u2013548 discussion 548-549","journal-title":"Surg Neurol"},{"issue":"11","key":"3833_CR43","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.004","volume":"25","author":"T Morimoto","year":"2016","unstructured":"Morimoto T, Mineharu Y, Kobayashi H, Harada KH, Funaki T, Takagi Y, Sakai N, Miyamoto S, Koizumi A (2016) Significant association of the RNF213 p.R4810K polymorphism with quasi-Moyamoya disease. J Stroke Cerebrovasc Dis 25(11):2632\u20132636. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.07.004","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"3833_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0887-8994(85)90036-0","volume":"1","author":"T Okuno","year":"1985","unstructured":"Okuno T, Prensky AL, Gado M (1985) The moyamoya syndrome associated with irradiation of an optic glioma in children: report of two cases and review of the literature. Pediatr Neurol 1(5):311\u2013316","journal-title":"Pediatr Neurol"},{"issue":"5","key":"3833_CR45","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/STROKEAHA.106.479733","volume":"38","author":"D Periard","year":"2007","unstructured":"Periard D, Boulanger CM, Eyer S, Amabile N, Pugin P, Gerschheimer C, Hayoz D (2007) Are circulating endothelial-derived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke? Stroke 38(5):1636\u20131638. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.106.479733","journal-title":"Stroke"},{"issue":"6","key":"3833_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3171\/2015.10.PEDS15537","volume":"17","author":"JH Phi","year":"2016","unstructured":"Phi JH, Choi JW, Seong MW, Kim T, Moon YJ, Lee J, Koh EJ, Ryu SK, Kang TH, Bang JS, Oh CW, Park SS, Lee JY, Wang KC, Kim SK (2016) Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1. J Neurosurg Pediatr 17(6):717\u2013722. \n                    https:\/\/doi.org\/10.3171\/2015.10.PEDS15537","journal-title":"J Neurosurg Pediatr"},{"issue":"6","key":"3833_CR47","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3340\/jkns.2015.57.6.408","volume":"57","author":"JH Phi","year":"2015","unstructured":"Phi JH, Wang KC, Lee JY, Kim SK (2015) Moyamoya syndrome: a window of Moyamoya disease. J Korean Neurosurg Soc 57(6):408\u2013414. \n                    https:\/\/doi.org\/10.3340\/jkns.2015.57.6.408","journal-title":"J Korean Neurosurg Soc"},{"issue":"3","key":"3833_CR48","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1542\/peds.2009-0152","volume":"124","author":"D Rea","year":"2009","unstructured":"Rea D, Brandsema JF, Armstrong D, Parkin PC, deVeber G, MacGregor D, Logan WJ, Askalan R (2009) Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics 124(3):e476\u2013e483. \n                    https:\/\/doi.org\/10.1542\/peds.2009-0152","journal-title":"Pediatrics"},{"key":"3833_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases (2012) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52:245\u2013266","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"3","key":"3833_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-0030-1255224","volume":"30","author":"LR Rogers","year":"2010","unstructured":"Rogers LR (2010) Cerebrovascular complications in patients with cancer. Semin Neurol 30(3):311\u2013319. \n                    https:\/\/doi.org\/10.1055\/s-0030-1255224","journal-title":"Semin Neurol"},{"issue":"3","key":"3833_CR51","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1212\/01.WNL.0000150544.00016.69","volume":"64","author":"TL Rosser","year":"2005","unstructured":"Rosser TL, Vezina G, Packer RJ (2005) Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 64(3):553\u2013555","journal-title":"Neurology"},{"issue":"3","key":"3833_CR52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1023\/A:1005809617292","volume":"37","author":"MS Rudoltz","year":"1998","unstructured":"Rudoltz MS, Regine WF, Langston JW, Sanford RA, Kovnar EH, Kun LE (1998) Multiple causes of cerebrovascular events in children with tumors of the parasellar region. J Neuro-Oncol 37(3):251\u2013261","journal-title":"J Neuro-Oncol"},{"issue":"5","key":"3833_CR53","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s11011-015-9668-y","volume":"30","author":"C Sam","year":"2015","unstructured":"Sam C, Li FF, Liu SL (2015) Inherited neurovascular diseases affecting cerebral blood vessels and smooth muscle. Metab Brain Dis 30(5):1105\u20131116. \n                    https:\/\/doi.org\/10.1007\/s11011-015-9668-y","journal-title":"Metab Brain Dis"},{"issue":"2","key":"3833_CR54","first-page":"159","volume":"36","author":"O Sasaki","year":"1984","unstructured":"Sasaki O, Ishii R, Koike T, Tanaka R (1984) Multiple cerebrovascular occlusive disease associated with neurofibromatosis. N\u014d to shinkei =. Brain nerve 36(2):159\u2013166","journal-title":"Brain nerve"},{"key":"3833_CR55","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"M Scott","year":"2009","unstructured":"Scott M, Smith ER (2009) Moyamoya disease and Moyamoya syndrome. N Engl J Med 360:1226\u20131237. \n                    https:\/\/doi.org\/10.1056\/NEJMra0804622","journal-title":"N Engl J Med"},{"key":"3833_CR56","first-page":"378","volume":"47","author":"RM Scott","year":"2000","unstructured":"Scott RM (2000) Moyamoya syndrome: a surgically treatable cause of stroke in the pediatric patient. Clin Neurosurg 47:378\u2013384","journal-title":"Clin Neurosurg"},{"issue":"2 Suppl Pediatr","key":"3833_CR57","first-page":"142","volume":"100","author":"RM Scott","year":"2004","unstructured":"Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA (2004) Long-term outcome in children with moyamoya syndrome after cranial revascularization by pialsynangiosis. J Neurosurg 100(2 Suppl Pediatrics):142\u2013149","journal-title":"J Neurosurg"},{"issue":"4","key":"3833_CR58","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/jmg.2010.081760","volume":"48","author":"S Sharif","year":"2011","unstructured":"Sharif S, Upadhyaya M, Ferner R, Majounie E, Shenton A, Baser M, Thakker N, Evans DG (2011) A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations. J Med Genet 48(4):256\u2013260. \n                    https:\/\/doi.org\/10.1136\/jmg.2010.081760","journal-title":"J Med Genet"},{"issue":"8784","key":"3833_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0140-6736(92)90141-O","volume":"339","author":"M Sharland","year":"1992","unstructured":"Sharland M, Patton MA, Talbot S, Chitolie A, Bevan DH (1992) Coagulation-factor deficiencies and abnormal bleeding in Noonan\u2019s syndrome. Lancet (London, England) 339(8784):19\u201321","journal-title":"Lancet (London, England)"},{"issue":"4","key":"3833_CR60","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2009.01.FOCUS08307","volume":"26","author":"ER Smith","year":"2009","unstructured":"Smith ER, McClain CD, Heeney M, Scott RM (2009) Pialsynangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus 26(4):E10. \n                    https:\/\/doi.org\/10.3171\/2009.01.FOCUS08307","journal-title":"Neurosurg Focus"},{"issue":"4","key":"3833_CR61","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2009.1.FOCUS08302","volume":"26","author":"JL Smith","year":"2009","unstructured":"Smith JL (2009) Understanding and treating moyamoya disease in children. Neurosurg Focus 26(4):E4. \n                    https:\/\/doi.org\/10.3171\/2000.01.FOCUS08306","journal-title":"Neurosurg Focus"},{"issue":"3","key":"3833_CR62","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1053\/scds.2001.26857","volume":"1","author":"JL Smith","year":"2001","unstructured":"Smith JL, Scott RM (2001) Treatment of moyamoya syndrome in children. Semin Cerebrovasc Dis Stroke 1(3):225\u2013239. \n                    https:\/\/doi.org\/10.1053\/scds.2001.26857","journal-title":"Semin Cerebrovasc Dis Stroke"},{"issue":"3","key":"3833_CR63","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A (1969) Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20(3):288\u2013299","journal-title":"Arch Neurol"},{"issue":"12","key":"3833_CR64","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1212\/01.wnl.0000257095.33125.48","volume":"68","author":"NJ Ullrich","year":"2007","unstructured":"Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL (2007) Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 68(12):932\u2013938. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000257095.33125.48","journal-title":"Neurology"},{"issue":"2","key":"3833_CR65","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/0883073810379639","volume":"26","author":"NJ Ullrich","year":"2011","unstructured":"Ullrich NJ, Zimmerman M, Smith E, Irons M, Marcus K, Kieran MW (2011) Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1. J Child Neurol 26(2):228\u2013230. \n                    https:\/\/doi.org\/10.1177\/0883073810379639","journal-title":"J Child Neurol"},{"issue":"6","key":"3833_CR66","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.pediatrneurol.2013.09.018","volume":"50","author":"C Wang","year":"2014","unstructured":"Wang C, Roberts KB, Bindra RS, Chiang VL, Yu JB (2014) Delayed cerebral vasculopathy following cranial radiation therapy for pediatric tumors. Pediatr Neurol 50(6):549\u2013556. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.09.018","journal-title":"Pediatr Neurol"},{"issue":"6","key":"3833_CR67","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.3171\/2011.3.FOCUS1150","volume":"30","author":"DG Weinberg","year":"2011","unstructured":"Weinberg DG, Rahme RJ, Aoun SG, Batjer HH, Bendok BR (2011) Moyamoya disease: functional and neurocognitive outcomes in the pediatric and adult populations. Neurosurg Focus 30(6):E21. \n                    https:\/\/doi.org\/10.3171\/2011.3.FOCUS1150","journal-title":"Neurosurg Focus"},{"issue":"1","key":"3833_CR68","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.devcel.2011.11.012","volume":"22","author":"R Wimmer","year":"2012","unstructured":"Wimmer R, Cseh B, Maier B, Scherrer K, Baccarini M (2012) Angiogenic sprouting requires the fine tuning of endothelial cell cohesion by the Raf-1\/Rok-a complex. Dev Cell 22(1):158\u2013171","journal-title":"Dev Cell"},{"issue":"5","key":"3833_CR69","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.pediatrneurol.2004.05.015","volume":"31","author":"Y Yamashita","year":"2004","unstructured":"Yamashita Y, Kusaga A, Koga Y, Nagamitsu S, Matsuishi T (2004) Noonan syndrome, moyamoya-like vascular changes, and antiphospholipid syndrome. Pediatr Neurol 31(5):364\u2013366. \n                    https:\/\/doi.org\/10.1016\/j.pediatrneurol.2004.05.015","journal-title":"Pediatr Neurol"},{"issue":"Suppl 2","key":"3833_CR70","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/S0303-8467(97)00042-5","volume":"99","author":"Y Yonekawa","year":"1997","unstructured":"Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG (1997) Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 99(Suppl 2):S58\u2013S60","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-018-3833-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-018-3833-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-018-3833-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T19:11:51Z","timestamp":1558638711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-018-3833-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3833"],"URL":"https:\/\/doi.org\/10.1007\/s00381-018-3833-7","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}